Shots:

• Qiagen has initiated the commercialization of the portable digital QIAreach SARS-CoV-2 antigen test in the US that can be used by laboratories to detect active infections in 2-15mins.
• The test provides a higher throughput testing for SARS-CoV-2 antigen by processing up to 8 tests/ hub. The digital results do not need subjective interpretation and enable Ab tests to run simultaneously with Ag tests
• QIAreach SARS-CoV-2 Ag test is a fast- digital- and easy to use a test that utilizes sensitive nanoparticle technology and is developed in partnership with Ellume. The company anticipate receiving CE-IVD registration for the EU and other markets by the end of 2020

­  Ref: Qiagen | Image: Holland One